StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PRVA

Privia Health Group, Inc.

PRVA Nasdaq Services-Health Services EDGAR ↗
$19.62
-0.25 -1.26%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$2.51B
Revenue (TTM) ⓘ
$2.36B
Net income (TTM) ⓘ
$28.1M
EPS (TTM) ⓘ
$0.22
P/E ratio ⓘ
89.2
Dividend yield ⓘ
—
Free cash flow ⓘ
$163M
Cash ⓘ
$412M
Total assets ⓘ
$1.49B
Gross margin ⓘ
—
52-week range ⓘ
$18.92 – $28.82

AI briefing

from the latest 10-K, 10-Q and 8-K events

Privia Health Group is a technology-driven physician-enablement company that organizes independent physicians into value-based care networks across 24 states and the District of Columbia.

What they do

Privia Health partners with physician practices, health plans, and health systems to form Medical Groups, providing management services, technology, and value-based care infrastructure. The company earns revenue through management fees and shared savings in government and commercial value-based programs, while also operating own medical groups in certain states.

Revenue drivers

  • Value-Based Care (VBC) Arrangements — Largest growth driver; attributed lives reached 1.647 million in Q2 2026, up 19.2% year-over-year, and the company focuses on transitioning providers from fee-for-service to risk-bearing models.
  • Owned Medical Groups — Company-owned practices where Privia holds majority interest and manages provider contracts and payer negotiations; these groups drive core practice collections and operating income.
  • Non-Owned Medical Groups and Privia Care Partners — Affiliation model providing VBC-only population health services, reporting, and management to practices in states where ownership isn't permitted or for providers seeking lighter integration.
  • Practice Collections — Represents total collections of all medical groups; Q2 2026 was $970.0 million, up 12.4% year-over-year, reflecting provider growth and higher patient volumes.

Recent performance

For Q2 2026 (ended June 30, 2026), revenue was $632.6 million, up 21.4% year-over-year, with net income of $9.0 million (up 236.7%). Adjusted EBITDA rose 29.1% to $37.4 million. Year-to-date 2026 revenue reached $1.24 billion, with net income of $12.1 million. Implemented providers grew to 5,644, up 10.1% from a year prior.

Strategy

Management's strategy is to scale nationally by entering new markets, organizing community-based physicians into regional Medical Groups, and migrating them from fee-for-service to value-based care, including commercial risk. The company invests in its Privia Technology Solution, data analytics, and revenue cycle management to improve provider economics. It also expands through the Privia Care Partners affiliation model and seeks to increase attributed lives across both government and commercial programs.

Risks

  • Regulatory and legal complexity — Privia operates in a heavily regulated healthcare environment; changes in laws or legal challenges to its Medical Group ownership structure could require significant operational changes.
  • Reimbursement rate pressure — Reductions in Medicare, Medicaid, or commercial payer reimbursement rates could adversely affect revenue and margins.
  • Dependence on Medical Groups and EMR vendor — The business relies on relationships with non-owned Medical Groups and its EMR vendor athenahealth; disruptions or lost contracts would impact operations.
  • Value-based care transition risk — Transitioning providers to risk-bearing arrangements may not yield expected savings or quality outcomes, potentially lowering profitability.

Outlook

For full-year 2026, management raised guidance for all key financial metrics: GAAP revenue at the high end of $2.35–$2.45 billion, Practice Collections at the high end of $3.65–$3.75 billion, and Attributed Lives raised to 1.625–1.650 million. Care Margin, Platform Contribution, and Adjusted EBITDA guidance were raised to mid-to-high end of prior ranges. The company expects continued provider and attributed life growth.

Recent SEC filings

40 most recent
Annual, quarterly & current reports